Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B
Roche has agreed to acquire Telavant Holdings, maker of an inflammatory bowel disease drug, from Roivant Sciences and Pfizer for $7.25 billion.
Source: beckershospitalreview.com
Page 11 - Phase 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phase 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phase 3 Today - Breaking & Trending Today
Filgotinib Misses Co-Primary Endpoints in Phase 3 DIVERSITY1 Study, Presented at ACG 2023
Presented in an abstract at ACG 2023, filgotinib missed both co-primary endpoints at week 10 but was efficacious at week 52 in the maintenance cohorts.
Source: hcplive.com
Live Microbiota Therapy Prevents Recurrent CDI in Older Adults with Comorbidity
New data presented at ACG 2023 showed an approximate 60% success rate of recurrent C difficile prevention in adults with comorbid conditions including CKD and cardiac disease.
Source: hcplive.com
Majority of Atopic Dermatitis Patients Maintained Clear Skin with Lebrikizumab Over 2 Years
These findings, presented at the Fall Clinical Dermatology conference, resulted from the ADjoin long-term extension study.
Source: hcplive.com
Low-Dose Amitriptyline Offers Viable Second-Line Treatment for IBS
Results from the phase 3 ATLANTIS study showed amitriptyline was superior to placebo across multiple symptom-based outcomes for patients with IBS.
Source: hcplive.com